MetroHealth Medical Center
metrohealth.orgTotal trials
103
Active
22
Phase 3
1
Total enrollment
9,898
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Gabapentin | — | — | — | — | — | 2 |
Next readouts
- 2026-08-31
Top conditions
- Stroke17
- Hemiplegia7
- Spinal Cord Injuries7
- Hemiparesis6
- Shoulder Pain5
- Obstructive Sleep Apnea4
- Paralysis4
- Wounds and Injuries3
Frequently asked questions about MetroHealth Medical Center
- How many clinical trials does MetroHealth Medical Center have on ClinicalTrials.gov?
- MetroHealth Medical Center is listed as the lead sponsor on 103 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of MetroHealth Medical Center's trials are in Phase 3?
- 1 of MetroHealth Medical Center's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does MetroHealth Medical Center focus on?
- MetroHealth Medical Center's most-studied conditions on ClinicalTrials.gov are Stroke, Hemiplegia, Spinal Cord Injuries, Hemiparesis, Shoulder Pain.
- When are MetroHealth Medical Center's next clinical trial readouts?
- MetroHealth Medical Center has 1 upcoming primary-completion readout tracked here; the soonest is “Feasibility of Early Gabapentin as an Intervention for Neurorecovery”, expected around 2026-08-31.